Moore Capital Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$977K Sell
44,390
-3,953
-8% -$79.4K 0.02% 425
2026
Q2
$992K Buy
48,343
+2,219
+5% +$37.6K 0.01% 496
2026
Q1
$733K Buy
+46,124
New +$1M 0.01% 394

Other funds holding FLGT

Moore Capital Management's FLGT Position: Q3 2026 in Review

Moore Capital Management reduced its Fulgent Genetics (FLGT) stake by 8.2% in Q3 2026, selling an estimated $79.4K and leaving 44,390 shares worth $977K. The position accounts for 0.02% of the portfolio, ranked #425.

Moore Capital Management first reported a position in FLGT in Q1 2026 and has held it in 3 quarters since. The position peaked at $992K in Q2 2026. 142 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Moore Capital Management held 44,390 shares of Fulgent Genetics worth $977K as of Q3 2026.
  • Moore Capital Management sold 3,953 Fulgent Genetics shares in Q3 2026, an estimated $79.4K.
  • Fulgent Genetics made up 0.02% of Moore Capital Management's portfolio in Q3 2026, its #425 holding.
  • Moore Capital Management first reported a position in Fulgent Genetics in Q1 2026 and has held it in 3 quarters since.
  • Moore Capital Management's Fulgent Genetics position peaked at $992K in Q2 2026.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Moore Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.